Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Valle

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
BJR Case Reports|September 14, 2022
Enhanced toxicity to chemoradiation in a patient with Anti-Jo-1-antisynthetase syndromeLuca Valle, James Katz, Austin Duffy, et al.
Journal of Clinical Pathology|February 22, 2019
Agar pre-embedding of small skin biopsies: real-life benefits and challenges in high throughput pathology laboratoriesMara Ridolfi, Michele Paudice, Sandra Salvi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2025
Validation and Derivation of miRNA-Based Germline Signatures Predicting Radiation Toxicity in Prostate CancerAmar U Kishan, Kristen McGreevy, Luca Valle, et al.
Pathologica|November 12, 2020
Non gastro-esophageal reflux disease related esophagitis: an overview with a histologic diagnostic approachLuca Mastracci, Federica Grillo, Paola Parente, et al.
International Journal of Radiation Oncology, Biology, Physics|January 4, 2025
Pelvic Regional Control With 25 Gy in 5 Fractions in Stereotactic Radiation Therapy for High-Risk Prostate Cancer: Pooled Prospective Outcomes From the SHARP ConsortiumVedang Murthy, Indranil Mallick, Priyamvada Maitre, et al.
Journal of Clinical Pathology|September 27, 2019
Lymph node number, surface area and lymph node ratio are important prognostic indicators in neoadjuvant chemoradiotherapy treated rectal cancerFrancesca Pitto, Gabriele Zoppoli, Stefano Scabini, et al.
European Urology Oncology|February 27, 2021
Use and Impact of Positron Emission Tomography/Computed Tomography Prior to Salvage Radiation Therapy in Men with Biochemical Recurrence After Radical Prostatectomy: A Scoping ReviewLuca Valle, David Shabsovich, Gert de Meerleer, et al.
International Journal of Oncology|April 19, 2022
Pilot trial of topical MTS‑01 application to reduce dermatitis in patients receiving chemoradiotherapy for stage I‑III carcinoma of the anal canalDeborah Citrin, Luca Valle, Kevin Camphausen, et al.
World Journal of Urology|March 16, 2024
Treatment intensification strategies for men undergoing definitive radiotherapy for high-risk prostate cancerJohn Nikitas, Amar Kishan, Albert Chang, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 29, 2025
Cervical cancer stage distribution and survival outcomes in Africa: a systematic review and meta-analysisChidinma Anakwenze, Anjali Kalra, Christian Lumley, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
BJR Case Reports|September 14, 2022
Enhanced toxicity to chemoradiation in a patient with Anti-Jo-1-antisynthetase syndromeLuca Valle, James Katz, Austin Duffy, et al.
Journal of Clinical Pathology|February 22, 2019
Agar pre-embedding of small skin biopsies: real-life benefits and challenges in high throughput pathology laboratoriesMara Ridolfi, Michele Paudice, Sandra Salvi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2025
Validation and Derivation of miRNA-Based Germline Signatures Predicting Radiation Toxicity in Prostate CancerAmar U Kishan, Kristen McGreevy, Luca Valle, et al.
Pathologica|November 12, 2020
Non gastro-esophageal reflux disease related esophagitis: an overview with a histologic diagnostic approachLuca Mastracci, Federica Grillo, Paola Parente, et al.
International Journal of Radiation Oncology, Biology, Physics|January 4, 2025
Pelvic Regional Control With 25 Gy in 5 Fractions in Stereotactic Radiation Therapy for High-Risk Prostate Cancer: Pooled Prospective Outcomes From the SHARP ConsortiumVedang Murthy, Indranil Mallick, Priyamvada Maitre, et al.
Journal of Clinical Pathology|September 27, 2019
Lymph node number, surface area and lymph node ratio are important prognostic indicators in neoadjuvant chemoradiotherapy treated rectal cancerFrancesca Pitto, Gabriele Zoppoli, Stefano Scabini, et al.
European Urology Oncology|February 27, 2021
Use and Impact of Positron Emission Tomography/Computed Tomography Prior to Salvage Radiation Therapy in Men with Biochemical Recurrence After Radical Prostatectomy: A Scoping ReviewLuca Valle, David Shabsovich, Gert de Meerleer, et al.
International Journal of Oncology|April 19, 2022
Pilot trial of topical MTS‑01 application to reduce dermatitis in patients receiving chemoradiotherapy for stage I‑III carcinoma of the anal canalDeborah Citrin, Luca Valle, Kevin Camphausen, et al.
World Journal of Urology|March 16, 2024
Treatment intensification strategies for men undergoing definitive radiotherapy for high-risk prostate cancerJohn Nikitas, Amar Kishan, Albert Chang, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 29, 2025
Cervical cancer stage distribution and survival outcomes in Africa: a systematic review and meta-analysisChidinma Anakwenze, Anjali Kalra, Christian Lumley, et al.
Pageof 5